Skip to main content

Advertisement

SpringerLink
Log in

Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin

  • Case Reports
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Percutaneous transhepatic portal vein embolization (PTPE) causes atrophy of the embolized lobe and compensatory hypertrophy of the nonembolized lobe, and improves the safety of hepatectomy. We report a patient with cholangiocarcinoma who underwent embolization of both anterior and posterior branches of the right portal vein before hepatectomy. Scintigraphy with Tc-99m galactosyl human serum albumin was performed before and 4 weeks after PTPE. After PTPE, the right lobe of the liver was atrophied and the left lobe of the liver was enlarged, compared with before PTPE. The receptor index of the entire liver was almost unchanged before and after PTPE, but the right lobe receptor index after PTPE was 23% less than the pre-PTPE value, whereas the left lobe receptor index had increased 37%. Scintigraphy with Tc-99m galactosyl human serum albumin is useful for evaluating segmental functional reserve before and after PTPE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tanaka H, Kinoshita H, Hirohashi K, Kubo S, Lee KC. Increased safety by two-stage hepatectomy with preoperative portal vein embolization in rats.J Surg Res 57: 687–692, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, et al. Efficacy of preoperative portal vein embolization prior to major hepatectomy for patients with impaired liver function: A retrospective study.J Hep Bil Pancr Surg 4: 359–364, 1997.

    Article  Google Scholar 

  3. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma.World J Surg 10: 803–808, 1986.

    Article  PubMed  CAS  Google Scholar 

  4. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage.Am J Gastroenteral 87: 865–870, 1992.

    CAS  Google Scholar 

  5. Koizumi K, Uchiyama G, Arai T, Ainoda T, Yoda Y. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters.Ann Nucl Med 6: 83–87, 1992.

    PubMed  CAS  Google Scholar 

  6. Wu J, Ishikawa N, Takada T, Tanaka Y, Pan QX, Sato M, et al. The functional hepatic volume assessed by99mTc-GSA hepatic scintigraphy.Ann Nucl Med 9: 229–235, 1995.

    PubMed  CAS  Google Scholar 

  7. Shiomi S, Kuroki T, Kuriyama M, Takeda T, Nishiguchi S, Nakajima S, et al. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.J Nucl Med 38: 79–82, 1998.

    Google Scholar 

  8. Nakajima K, Kinuya K, Mizutani Y, Hang E-H, Michigishi T, Tonami N, et al. Simple scintigraphic parameters with Tc-99m galactosyl human serum albumin for clinical staging of chronic hepatocellular dysfunction.Ann Nucl Med 13: 5–11, 1999.

    Article  PubMed  CAS  Google Scholar 

  9. Toyama H, Ito K, Komori Y, Sugioka A, Shibata K, Komai S, et al. Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agents.KAKU IGAKU (Jpn J Nucl Med) 32: 323–329, 1995.

    CAS  Google Scholar 

  10. Noguchi A, Hasegawa Y, Sasaki Y, Imaoka S, Hashizume T, Ibuka K, et al. Changes of liver function measured by99mTc-GSA scintigraphy after hepatectomy.KAKU IGAKU (Jpn J Nucl Med) 32: 419–426, 1995.

    CAS  Google Scholar 

  11. Kosuda S, Shioyama Y, Suzuki K, Hayashi S, Tanaka S. Assessment of liver function using99mTc-GSA in patients with chronic liver disease and/or hepatocellular carcinoma before and after transcatheter arterial embolization.KAKU IGAKU (Jpn J Nucl Med) 28: 1385–1392, 1991.

    CAS  Google Scholar 

  12. Kohda K, Ha-Kawa SK, Yamano R, Murata T, Harima K, Tanaka Y, et al. Changes in lobar uptake of99mTc-galactosyl serum albumin after transhepatic embolization therapy.Nippon Igaku Hoshasen Gakkai Zasshi 54: 1427–1429, 1994.

    PubMed  CAS  Google Scholar 

  13. Nagino M, Nimura Y, Kamiya J, Kanai M, Uesaka K. Surgical treatment of hilar cholangiocarcinoma.Nippon Geka Gakkai Zasshi 98: 491–494, 1997.

    PubMed  CAS  Google Scholar 

  14. Imaeda T, Kanematsu M, Asada S, Seki M, Doi H, Saji S. Utility of Tc-99m GSA SPECT imaging in estimation of functional volume of liver segments in health and liver diseases.Clin Nucl Med 20: 322–328, 1995.

    Article  PubMed  CAS  Google Scholar 

  15. Matsuzaki S, Onda M, Tajiri T, Kim DY. Hepatic lobar differences in progression of chronic liver disease: Correlation of asialoglycoprotein scintigraphy and hepatic functional reserve.Hepatology 25: 828–832, 1997.

    Article  PubMed  CAS  Google Scholar 

  16. Wu J, Ishikawa N, Takeda T, Sato M, Fukunaga K, Todoroki T, et al. Evaluation of reserve hepatic function in patients with hepatobiliary tumor by99mTc-GSA: Effect of hyperbilirubinemia and usefulness of regional hepatic functional imaging.KAKU IGAKU (Jpn J Nucl Med) 33: 161–168, 1996.

    CAS  Google Scholar 

  17. Ohtake E, Masumura M. Discordance of Tc-99m PMT and Tc-99m GSA in constitutional hyperbilirubinemia.Clin Nucl Med 21: 744–745, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Shuhei Nishiguchi, Susumu Shiomi, Nobumitsu Sasaki & Yoshinori Iwata

  2. Second Department of Surgery, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-Ku, 545-8585, Osaka, Japan

    Shinichi Mikami, Hiromu Tanaka & Shoji Kubo

  3. Division of Nuclear Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, 545-8585, Osaka, Japan

    Hironobu Ochi

Authors
  1. Shuhei Nishiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susumu Shiomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobumitsu Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshinori Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shinichi Mikami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiromu Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shoji Kubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hironobu Ochi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susumu Shiomi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishiguchi, S., Shiomi, S., Sasaki, N. et al. Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin. Ann Nucl Med 14, 231–234 (2000). https://doi.org/10.1007/BF02987867

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02987867

Key words

Search

Navigation